Skip to main content

Table 2 DSS for full cohort of lung cancer patients (N = 243)

From: Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment

 

Estimated disease-specific survival probabilities (in per cent, with 95% confidence intervals, CI) at 1, 3, and 5 years by different methods1

Methods:

1

3

5

Boag

81 (79,83)

28 (26,30)

19 (17,21)

Kaplan-Meier

82 (78,87)

26 (20,31)

19 (14,25)

Cox

82 (77,87)

26 (20,31)

19 (14,25)

Log-normal survival analysis

80 (76,83)

38 (33,43)

20 (17,24)

  1. 1By 1 year, 42 of 238 (17.6%) of patients died from lung cancer; by 3 years, 173 of 230 (75.2%); and by 5 years, 186 of 223 (83.4%).